Stephanie Noone

Dr. Stephanie Noone

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2022 in Haemophilia
Verified
Journal Article
Open access
SNStephanie Noone
Stephanie Noone
RSRalf Schubert
Ralf Schubert
SFStephan Fichtlscherer
Stephan Fichtlscherer
THThomas Hilberg
Thomas Hilberg
SASonja Alesci
Sonja Alesci
UWUdo F. Wehmeier
Udo F. Wehmeier
Introduction: Elevated markers of endothelial dysfunction and inflammation indicate worse endothelial function in the aging haemophilia population. MicroRNAs (miRNAs) regulate gene expression post‐transcriptionally. Several miRNAs have been shown to be involved in the process of endothelial dysfunction and atherosclerosis.Aim: The aim of this study was to determine the underlying molecular pathways of endothelial dysfunction and inflammation in haemophilia patients.Methods: A total of 25 patients with severe or moderate haemophilia A (20 patients) or B (5 patients), 14 controls and 18 patients with coronary artery disease (CAD) after myocardial infarction were included in this study. Expression of miRNA‐126, ‐155, ‐222, ‐1, ‐let7a, ‐21 and ‐197 were analysed using a real time polymerase chain reaction. Network‐based visualisation and analysis of the miRNA‐target interactions were performed using the MicroRNA ENrichment TURned NETwork (MIENTURNET).Results: Expression of miRNA‐126 (p < .05) and miRNA‐let7a (p < .05) were significantly higher in CAD patients compared to haemophilia patients and controls. MiRNA‐21 (p < .05) was significantly elevated in CAD patients compared to controls. MiRNA‐155 (p < .05), miRNA‐1 (p < .05) and miRNA‐197 (p < .05) were significantly higher expressed in CAD and haemophilia patients compared to controls and showed a strong correlation with increased levels of interleukin‐6 (IL‐6) and soluble intercellular adhesion molecule‐1 (sICAM‐1). The network analysis revealed interactions in the cytokine signalling, focal adhesion and VEGFA‐VEGFR2 pathway (Vascular endothelial growth factor, ‐receptor).Conclusion: This study characterises miRNA expression in haemophilia patients in comparison to CAD patients and healthy controls. The results imply comparable biological processes in CAD and haemophilia patients.

13 February 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
VNVanessa Neef
Vanessa Neef
AFArmin Niklas Flinspach
Armin Niklas Flinspach
KEKatrin Eichler
Katrin Eichler
TWTirza R. Woebbecke
Tirza R. Woebbecke
SNStephanie Noone
Stephanie Noone
FRFlorian Jürgen Raimann
Florian Jürgen Raimann
Background: Placenta accreta spectrum (PAS) disorders are a continuum of placental pathologies with increased risk for hemorrhage, blood transfusion and maternal morbidity. Uterine artery embolization (UAE) is a safe approach to the standardization of complex PAS cases. The aim of this study is to analyze anemia and transfusion rate, outcome and anesthesiological management of women who underwent caesarean delivery with subsequent UAE for the management of PAS. Material and Methods: This retrospective observational study included all pregnant women admitted to the University Hospital Frankfurt between January 2012 and September 2023, with a diagnosis of PAS who underwent a two-step surgical approach for delivery and placenta removal. Primary procedure included cesarean delivery with subsequent UAE, secondary procedure included placenta removal after a minim of five weeks via curettage or HE. Maternal characteristics, anesthesiological management, complications, anemia rate, blood loss and administration of blood products were analyzed. Results: In total, 17 women with PAS were included in this study. Of these, 5.9% had placenta increta and 94.1% had placenta percreta. Median blood loss was 300 (200–600) mL during primary procedure and 3600 (450–5500) mL during secondary procedure. In total, 11.8% and 62.5% of women received red blood cell transfusion during the primary and secondary procedures, respectively. After primary procedure, postpartum anemia rate was 76.5%. The HE rate was 64.7%. Regional anesthesia was used in 88.2% during primary procedure. Conclusion: The embolization of the uterine artery for women diagnosed with PAS is safe. Anemia management and the implementation of blood conservation strategies are crucial in women undergoing UAE for the management of PAS.

1 January 2021 in Clinical and Applied Thrombosis/Hemostasis
Verified
Journal Article
Open access
PDF file
SNStephanie Noone
Stephanie Noone
RSRalf Schubert
Ralf Schubert
SFStephan Fichtlscherer
Stephan Fichtlscherer
THThomas Hilberg
Thomas Hilberg
SASonja Alesci
Sonja Alesci
WMWolfgang Miesbach
Wolfgang Miesbach
In patients with von Willebrand disease (vWD) the interest in age-related comorbidities has grown, because the life expectancy of these patients has increased. The research question of this study was whether patients with vWD show a different endothelial function compared to the general population. A total of 37 patients with type 1 (n = 23), type 2 (n = 10) and type 3 (n = 4) vWD, 14 controls and 38 patients with coronary artery disease (CAD) were included in this study. Five markers of endothelial dysfunction (MOED) were determined. Moreover, the endothelial function was examined using the Itamar Endo-PAT. The reactive hyperemia index (RHI) was calculated from the results. The markers soluble intercellular adhesion molecule-1 (p = 0.171), P-Selectin (p = 0.512), interleukin-6 (p = 0.734) and monocyte chemoattractant protein-1 (p = 0.761) showed higher levels in patients with vWD, but were not significantly different compared to the control group. RHI was impaired in CAD-patients (1.855), whereas vWD patients had mean results of 1.870 and controls 2.112 (p = 0.367). In this study, the endothelial function measurements of patients with von Willebrand disease were not significantly different compared to healthy controls.

29 April 2023 in Children
Verified
Journal Article
Open access
PDF file
FPFlorian Piekarski
Florian Piekarski
SNStephanie Noone
Stephanie Noone
TEThomas Engelhardt
Thomas Engelhardt
MHMartin Hellmich
Martin Hellmich
EWEva Wittenmeier
Eva Wittenmeier
Jost KaufmannJost Kaufmann
Jost Kaufmann
Background: Transfusion of red blood cell concentrate can be life-saving, but requires accurate dose calculations in children. Aims: We tested the hypothesis that cognitive aids would improve identification of the correct recommended volumes and products, according to the German National Transfusion guidelines, in pediatric transfusion scenarios. Methods: Four online questionnaire-based scenarios, two with hemodynamically stable and two with hemodynamically unstable children, were sent to German and international pediatric anesthetists for completion. In the two stable scenarios, participants were given pre-filled tables that contained all required information. For the two emergency scenarios, existing algorithms were used and required calculation by the user. The results were classified into three categories of deviations from the recommended values (DRV): DRV120 (120%), as the acceptable variation; DRV 300 (300%), the deviation of concern for potential harm; and DRV 1000 (1000%), the excessive deviation with a high probability of harm. Results: A total of 1.458 pediatric anesthetists accessed this simulation questionnaire, and 402 completed questionnaires were available for analysis. A pre-filled tabular aid, avoiding calculations, led to a reduction in deviation rates in the category of DRV120 by 60% for each and of DRV300 by 17% and 20%, respectively. The use of algorithms as aids for unstable emergencies led to a reduction in the deviation rate only for DRV120 (20% and 15% respectively). In contrast, the deviation rates for DRV300 and DRV1000 rose by 37% and 16%, respectively. Participants used higher transfusion thresholds for the emergency case of a 2-year-old compromised child than for the stable case with a patient of the same age (on average, 8.6 g/dL, 95% CI 8.5–8.8 versus 7.1 g/dL, 95% CI 7.0–7.2, p < 0.001) if not supported by our aids. Participants also used a higher transfusion threshold for unstable children aged 3 months than for stable children of the same age (on average, 8.9 g/dL, 95% CI 8.7–9.0 versus 7.9 g/dL, 95% CI 7.7–8.0, p < 0.001). Conclusions: The use of cognitive aids with precalculated transfusion volumes for determining transfusion doses in children may lead to improved adherence to published recommendations, and could potentially reduce dosing deviations outside those recommended by the German national transfusion guidelines.